FK 506 for liver, kidney, and pancreas transplantation.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  The Lancet

• Publication date

  1989-10-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(89)91014-3PMID 2478846PMCID PMC2966318
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impaired Endothelium‐Dependent Relaxation to Aggregating Platelets and Related Vasoactive: Substances in Porcine Coronary Arteries in Hypercholesterolemia and Atherosclerosis

  1989cited by this paper
• Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation

  1989cited by this paper
• Nitric oxide synthesised from L-arginine mediates endothelium dependent dilatation in human veins in vivo.

  1989cited by this paper
• Effects of combination treatment with FK506 and cyclosporine on survival time and vascular changes in renal-allograft-recipient dogs.

  1989cited by this paper
• Renal transplantation in baboons under FK 506.

  1989cited by this paper
• Renal transplantation in baboons under FK 506.

  1989cited by this paper
• NG-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo?

  1989cited by this paper
• Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm.

  1989cited by this paper
• Vascular endothelial cells synthesize nitric oxide from L-arginine

  1988cited by this paper
• Pancreatico-duodenal transplantation with enteric exocrine drainage

  1988cited by this paper
• The Discovery of Nitric Oxide as the Endogenous Nitrovasodilator

  1988cited by this paper
• Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction.

  1988cited by this paper
• L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation.

  1988cited by this paper
• Immunologic control of hemopoiesis: implications for quality of the graft after allogeneic bone marrow transplantation.

  1987cited by this paper
• Development and structure of the scientific program of the Eleventh Congress.

  1987cited by this paper
• EDRF coordinates the behaviour of vascular resistance vessels

  1987cited by this paper
• Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine.

  1987cited by this paper
• Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids.

  1987cited by this paper
• FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.

  1987cited by this paper
• First International Workshop on FK-506. A potential breakthrough in immunosuppression. Proceedings.

  1987cited by this paper
• Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium.

  1987cited by this paper
• Pathological studies in canine and baboon renal allograft recipients immunosuppressed with FK-506.

  1987cited by this paper
• FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.

  1987cited by this paper
• A highly sensitive method to assay FK-506 levels in plasma.

  1987cited by this paper
• Orthotopic liver transplantation in dogs receiving FK-506.

  1987cited by this paper
• Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat.

  1987cited by this paper
• In vitro correlates of graft-host tolerance after HLA-matched and mismatched marrow transplants: suggestions from limiting dilution analysis.

  1987cited by this paper
• FK-506 - A POTENTIAL BREAKTHROUGH IN IMMUNOSUPPRESSION

  1987cited by this paper
• Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries.

  1986cited by this paper
• The role of endothelium in the responses of vascular smooth muscle to drugs.

  1984cited by this paper
• Pancreaticoduodenal transplantation in humans.

  1984cited by this paper
• The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

  1980cited by this paper
• Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers.

  1979cited by this paper
• Endogenous prostaglandins as local regulators of blood flow in man: effect of indomethacin on reactive and functional hyperaemia.

  1976cited by this paper
• The effect of intra-arterial antihistamines on the hyperaemia following temporary arrest of the circulation in the human forearm.

  1955cited by this paper
• The measurement of volume changes in human limbs

  1953cited by this paper

• The importance of staying within range: associations between tacrolimus intrapatient variability and kidney transplant outcomes

  2026cites this paper
• Immunosuppression Post-Liver Transplant: End of the Calcineurin Era?

  2025cites this paper
• Dr. Thomas Starzl (1926-2017): Father of Liver Transplantation.

  2025cites this paper
• Surgery, Science, and Stewardship: The Changing Profile of the Abdominal Transplant Surgeon

  2025cites this paper
• Liver Transplantation Outcomes in Younger Versus Older Adult Recipients: The Edmonton Experience

  2025cites this paper
• Drug-drug interaction between trastuzumab emtansine (T-DM1) and orally administered tacrolimus in a patient and in rats.

  2025cites this paper
• Immunosuppressive Therapy in Pediatric Kidney Transplantation: Evolution, Current Practices, and Future Directions

  2025cites this paper
• MAGLUMI® Tacrolimus (CLIA) assay: analytical performances and comparison with LC-MS/MS and ARCHITECT Tacrolimus (CMIA) assay

  2025cites this paper
• Lesson learnt from 60 years of liver transplantation: Advancements, challenges, and future directions

  2025cites this paper
• Monitoring of Allograft Adaptation After Kidney Transplantation in Pediatric Patients by Targeted Plasma Metabolomics

  2025cites this paper
• Bibliometric and LDA analysis of acute rejection in liver transplantation: Emerging trends, immunotherapy challenges, and the role of artificial intelligence

  2025cites this paper
• Mechanisms of Tolerance Induction in Liver Transplantation: Lessons Learned from Fetomaternal Tolerance, Autoimmunity and Tumor Immunity

  2024cites this paper
• New insights in immunomodulation for intestinal transplantation.

  2024cites this paper
• Role of calcineurin in regulating renal potassium (K+) excretion: Mechanisms of calcineurin inhibitor‐induced hyperkalemia

  2024cites this paper
• The Effect of Pringle Maneuver Applied during Living Donor Hepatectomy on the Ischemia-Reperfusion Injury Observed in the Donors and Recipients

  2024cites this paper
• The Story of FK 506 Begins with Thomas E. Starzl

  2024cites this paper
• A descriptive study of the single-nucleotide polymorphisms known to affect the Tacrolimus trough concentration per dose, among a population of kidney failure patients in a tertiary hospital in Ghana

  2024cites this paper
• The future of liver transplantation

  2024cites this paper
• Long-Term Survival of Canadian Liver Transplant Recipients Remains Stagnant— A Cohort Study on the Evolution of Cause-Specific Mortality

  2024cites this paper
• Intestinal Re-Transplantation.

  2024cites this paper
• Iscalimab Combined With Transient Tesidolumab Prolongs Survival in Pig‐to‐Rhesus Monkey Renal Xenografts

  2024cites this paper
• Factors influencing intrapatient variability of tacrolimus and its association with 1-year post-transplant outcomes in pediatric liver transplant recipients

  2024cites this paper
• Update on Maintenance Immunosuppression in Intestinal Transplantation.

  2024cites this paper
• The Immunosuppressant Tacrolimus (FK506) Facing the 21st Century: Past Findings, Present Applications and Future Trends

  2024cites this paper
• A review of landmark studies on maintenance immunosuppressive regimens in kidney transplantation

  2024cites this paper
• Animal models for transplant immunology: bridging bench to bedside

  2024cites this paper
• Nerve Wrap for Local Delivery of FK506/Tacrolimus Accelerates Nerve Regeneration

  2024cites this paper
• Updates in induction immunosuppression regimens for intestinal transplantation.

  2024cites this paper
• Chinese contributions to liver transplantation.

  2024cites this paper
• Enhanced fungal specificity and in vivo therapeutic efficacy of a C-22-modified FK520 analog against C. neoformans

  2023cites this paper
• Profile of Liver Transplant Recipient in a Tertiary Hospital in Northern Spain

  2023cites this paper
• Enhanced fungal specificity and in vivo therapeutic efficacy of a C-22 modified FK520 analog against C. neoformans

  2023influential citation
• Conventional and Novel Approaches to Immunosuppression in Lung Transplantation.

  2023cites this paper
• Comparative effects of hepatocyte growth factor and tacrolimus on acute liver allograft early tolerance

  2023cites this paper
• Therapeutic strategies for peripheral nerve injuries: FK506 and electrostimulation

  2023cites this paper
• Clinical application of immune repertoire sequencing in solid organ transplant

  2023cites this paper
• Evolving challenges with long‐term care of liver transplant recipients

  2023cites this paper
• Kidney transplantation: The journey across a century.

  2023cites this paper
• Should we abandon therapeutic drug monitoring of tacrolimus in whole blood and move to intracellular concentration measurements?

  2023cites this paper
• Neuroprotective Action of Tacrolimus before and after Onset of Neonatal Hypoxic–Ischaemic Brain Injury in Rats

  2023cites this paper
• Peripheral Nerve Regeneration: Opportunities and Challenges

  2023cites this paper
• Tremor Induced by Cyclosporine, Tacrolimus, Sirolimus, or Everolimus: A Review of the Literature

  2023cites this paper
• Predictive Factors for Efficacy of Oral Tacrolimus Induction Therapy in Moderate to Severe Ulcerative Colitis Patients: Large Multicenter Retrospective Cohort Study.

  2023cites this paper
• Immunosuppressive drugs and associated complications in abdominal organ transplantation

  2022cites this paper
• Long-lasting renal dysfunction following tacrolimus induction therapy in ulcerative colitis patients

  2022cites this paper
• The most influential articles on kidney transplantation

  2022cites this paper
• Structure-Guided Synthesis of FK506 and FK520 Analogs with Increased Selectivity Exhibit In Vivo Therapeutic Efficacy against Cryptococcus

  2022cites this paper
• Case Report: Let Us Not Forget the Treatment That Some Patients Have Received—The Brief 50-Year History of a Kidney Transplant Survivor

  2022cites this paper
• Local delivery of tacrolimus using electrospun poly-ϵ-caprolactone nanofibres suppresses the T-cell response to peripheral nerve allografts

  2022cites this paper
• Host and immunosuppression-related factors influencing fibrosis occurrence post liver transplantation

  2022cites this paper
• Targeting calcineurin induces cardiomyocyte proliferation in adult mice

  2022cites this paper
• Dr. Thomas Earl Starzl (1926–2017): Father of Transplantation

  2022cites this paper
• Immunosuppression and liver transplantation

  2022cites this paper
• Immunosuppression in liver and intestinal transplantation.

  2021cites this paper
• Mesenchymal stem cells and local tacrolimus delivery synergistically enhance neurite extension

  2021cites this paper
• Effects and safety evaluation of Wuzhi Capsules combined with tacrolimus for the treatment of kidney transplantation recipients

  2021cites this paper
• Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19?

  2021cites this paper
• Kidney Allograft Fibrosis: Diagnostic and Therapeutic Strategies

  2021cites this paper
• Quantitative Analysis of Immunosuppressive Drugs Using Tungsten Disulfide Nanosheet-Assisted Laser Desorption Ionization Mass Spectrometry.

  2021cites this paper
• Advances in Rejection Management: Prevention and Treatment.

  2021cites this paper
• Efficacy and safety of once daily tacrolimus compared to twice daily tacrolimus after liver transplantation

  2021cites this paper
• Glutathione Liposomes Carrying Ceftriaxone, FK506, and Nilotinib to Control Overexpressed Dopamine Markers and Apoptotic Factors in Neurons.

  2021cites this paper
• History of organ transplantation and the development of key immunosuppressants

  2020cites this paper
• Effectiveness and Nephrotoxicity of Long-Term Tacrolimus Administration in Patients with Ulcerative Colitis

  2020cites this paper
• The Many Faces of Calcineurin Inhibitor Toxicity-What the FK?

  2020cites this paper
• THIRTY YEARS OF TACROLIMUS IN CLINICAL PRACTICE.

  2020cites this paper
• Local Immunosuppression for Vascularized Composite Allografts: Application of Topical FK506-TyroSpheres in a Non-Human Primate Model.

  2020cites this paper
• Role of tacrolimus in return of hand function after brachial plexus injury in a lung transplantation patient

  2020cites this paper
• Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology

  2020cites this paper
• Cyclosporine and COVID-19: Risk or favorable?

  2020cites this paper
• Organ Transplantation: A Historical Perspective

  2020cites this paper
• Pancreas transplantation, bioengineering, and regeneration

  2020cites this paper
• Modulatory effect of rapamycin and tacrolimus on monocyte-derived dendritic cells phenotype and function.

  2020cites this paper
• The pharmacogenetics of tacrolimus and its implications for personalized therapy in kidney transplant recipients

  2020cites this paper
• Proteomic Characterization of Urinary Extracellular Vesicles from Kidney-Transplanted Patients Treated with Calcineurin Inhibitors

  2020cites this paper
• The Role of Visceral Transplantation for Neoplastic Disease

  2020cites this paper
• Tacrolimus: 20 years of use in adult kidney transplantation; what we should know about its nephrotoxicity.

  2020cites this paper
• The establishment of a novel high-throughput screening system using RNA-guided genome editing to identify chemicals that suppress aldosterone synthase expression.

  2020cites this paper
• Effects of Cyclosporin-A, Minocycline, and Tacrolimus (FK506) on Enhanced Behavioral and Biochemical Recovery from Spinal Cord Injury in Rats

  2019cites this paper
• Lebertransplantation bei primären Lebertumoren und Lebermetastasen

  2019cites this paper
• Immunosuppressive Therapy

  2019cites this paper
• Pediatric Diabetes: Review Article

  2019cites this paper
• Organ Transplantation

  2019cites this paper
• Immunosuppressive Drug Levels in Liver Transplant Recipients: Impact in Decision Making

  2019cites this paper
• Visceral Transplantation: Current Trends and Long-Term Outcome

  2019cites this paper
• Effects of Wuzhi Capsules on Blood Concentration of Tacrolimus in Renal Transplant Recipients

  2019cites this paper
• Transplantation Surgery

  2019cites this paper
• mTOR Inhibitors

  2019cites this paper
• Composite and Multivisceral Transplantation: Nomenclature, Surgical Techniques, Current Practice, and Long-term Outcome.

  2019cites this paper
• Intestinal Transplantation

  2019cites this paper
• Tacrolimus-induced diabetic ketoacidosis with subsequent rapid recovery of endogenous insulin secretion after cessation of tacrolimus

  2019cites this paper
• Exploring the neuroregenerative potential of tacrolimus

  2019influential citation
• Mycophenolates: The latest modern and potent immunosuppressive drugs in adult kidney transplantation: what we should know about them?

  2019cites this paper
• Multivisceral and Modified Multivisceral Intestinal Transplantation

  2019cites this paper
• Cyclosporine A inhibits MRTF‐SRF signaling through Na+/K+ ATPase inhibition and actin remodeling

  2019cites this paper
• Simultaneous Estimation by RP-HPLC Method for the Immunosuppressant Drug Combination: Mycophenolate Mofetil, Tacrolimus with Prednisolone

  2019cites this paper
• Sustained Release of Immunosuppressant by Nanoparticle-anchoring Hydrogel Scaffold Improved the Survival of Transplanted Stem Cells and Tissue Regeneration

  2018cites this paper
• Side effects and efficacy of renal sparing immunosuppression in pediatric liver transplantation—A single center matched cohort study

  2018cites this paper
• Heart transplantation: a history lesson of Lazarus

  2018cites this paper
• MECHANISM OF FK 506-INDUCED GLUCOSE INTOLERANCE IN RATS 61

  2018cites this paper